{
  "id": [
    "32404898"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32404898"
  ],
  "pmcid": [
    "PMC7220586"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7220586"
      ]
    }
  ],
  "doi": [
    "10.1038/s41430-020-0652-1"
  ],
  "title": [
    "Diabetes and COVID-19: evidence, current status and unanswered research questions."
  ],
  "authorString": [
    "Gupta R, Hussain A, Misra A."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Gupta R"
          ],
          "firstName": [
            "Ritesh"
          ],
          "lastName": [
            "Gupta"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Fortis CDOC Hospital, Chirag Enclave, New Delhi, India."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Hussain A"
          ],
          "firstName": [
            "Akhtar"
          ],
          "lastName": [
            "Hussain"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Chronic Disease-Diabetes, NORD University, Stj√∏rdal, Norway.",
                "Medicine, Federal University of Ceara (UFC), Ceara, Brazil."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Misra A"
          ],
          "firstName": [
            "Anoop"
          ],
          "lastName": [
            "Misra"
          ],
          "initials": [
            "A"
          ],
          "authorId": [
            {
              "_": "0000-0001-5785-5833",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Fortis CDOC Hospital, Chirag Enclave, New Delhi, India. anoopmisra@gmail.com.",
                "National Diabetes, Obesity and Cholesterol Foundation, New Delhi, India. anoopmisra@gmail.com.",
                "Diabetes Foundation (India), New Delhi, India. anoopmisra@gmail.com."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-5785-5833",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "6"
      ],
      "volume": [
        "74"
      ],
      "journalIssueId": [
        "2966415"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "European journal of clinical nutrition"
          ],
          "ISOAbbreviation": [
            "Eur J Clin Nutr"
          ],
          "medlineAbbreviation": [
            "Eur J Clin Nutr"
          ],
          "NLMid": [
            "8804070"
          ],
          "ISSN": [
            "0954-3007"
          ],
          "ESSN": [
            "1476-5640"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "864-870"
  ],
  "abstractText": [
    "Patients with diabetes who get coronavirus disease 2019 (COVID-19) are at risk of a severe disease course and mortality. Several factors especially the impaired immune response, heightened inflammatory response and hypercoagulable state contribute to the increased disease severity. However, there are many contentious issues about which the evidence is rather limited. There are some theoretical concerns about the effects of different anti-hyperglycaemic drugs. Similarly, despite the recognition of angiotensin converting enzyme 2 (ACE2) as the receptor for severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), and the role of ACE2 in lung injury; there are conflicting results with the use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) in these patients. Management of patients with diabetes in times of restrictions on mobility poses some challenges and novel approaches like telemedicine can be useful. There is a need to further study the natural course of COVID-19 in patients with diabetes and to understand the individual, regional and ethnic variations in disease prevalence and course."
  ],
  "affiliation": [
    "Fortis CDOC Hospital, Chirag Enclave, New Delhi, India."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Diabetes Mellitus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Peptidyl-Dipeptidase A"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Angiotensin-Converting Enzyme Inhibitors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hypoglycemic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Hypoglycemic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Angiotensin-Converting Enzyme Inhibitors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Peptidyl-Dipeptidase A"
          ],
          "registryNumber": [
            "EC 3.4.15.1"
          ]
        },
        {
          "name": [
            "angiotensin converting enzyme 2"
          ],
          "registryNumber": [
            "EC 3.4.17.-"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1038/s41430-020-0652-1"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7220586"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7220586?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "9"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-06-29"
  ],
  "dateOfCreation": [
    "2020-05-15"
  ],
  "firstIndexDate": [
    "2020-05-15"
  ],
  "fullTextReceivedDate": [
    "2020-07-11"
  ],
  "dateOfRevision": [
    "2020-10-16"
  ],
  "electronicPublicationDate": [
    "2020-05-13"
  ],
  "firstPublicationDate": [
    "2020-05-13"
  ]
}